Cannabinoid Receptor Ligands for Precise Dosing and Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for isolating and delivering cannabinoids for medicinal use face challenges such as low bioavailability, difficulty in maintaining proper dosing, and exposure to carcinogens through smoking, along with issues in isolating individual cannabinoids at high purity for medical and research purposes.
Innovation Solution
Development of novel cannabinoid receptor ligands, including compounds of formulas (I), (II), and (III), which can act as ligands to cannabinoid receptors and potentially modulate their activity, thereby providing therapeutic benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If smoking medical cannabis is used for therapeutic purposes, then the pharmacological benefits are achieved, but carcinogens and toxins are introduced causing lung damage
Solution Approach 1:
The patent extracts and isolates specific cannabinoids (such as CBD, THC, and their derivatives) from the cannabis plant through various extraction methods. This allows the therapeutic compounds to be separated from the plant material that contains carcinogens and toxins, enabling delivery of the active ingredients without the harmful components.
Solution Approach 2:
The patent employs various delivery systems and formulations (such as oils, tinctures, capsules, and transdermal preparations) that serve as intermediaries to deliver cannabinoids to the body. These delivery vehicles allow the cannabinoids to be absorbed without requiring combustion, thus avoiding the introduction of carcinogens while maintaining therapeutic efficacy.
2Reliability
If smoking medical cannabis is used, then cannabinoid delivery is achieved, but proper dosing control becomes difficult due to variability in plant strains and growing conditions
Solution Approach 1:
The patent focuses on isolating and standardizing specific cannabinoids with known pharmacological properties and dosing requirements. By concentrating on pure compounds rather than variable plant material, the invention enables precise control over the amount of active ingredient delivered, regardless of the original plant's variability in strain or growing conditions.
Solution Approach 2:
The patent replaces the mechanical process of smoking and inhalation with controlled delivery systems such as oral formulations, transdermal patches, and sublingual preparations. These systems allow for pre-measured, consistent dosing that is not dependent on the user's inhalation technique or the plant material's combustion characteristics.
3Reliability
If smoking medical cannabis is used, then cannabinoid absorption occurs, but bioavailability of target compounds remains relatively low
Solution Approach 1:
The patent employs various formulation strategies including the use of lipids, emulsifiers, and penetration enhancers that change the physical and chemical parameters of the cannabinoid delivery system. These modifications improve the solubility, stability, and permeability of cannabinoids, thereby enhancing their bioavailability through non-smoking routes of administration.
Data Source
AI summary
The present invention are directed to cannabinoid derivatives and compositions thereof.